The company expired its plan on June 21, 2023.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+33.34% | 700B | |
-4.90% | 358B | |
+18.86% | 330B | |
+3.43% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.81% | 161B | |
-2.22% | 157B |